论文部分内容阅读
应用血管扩张剂治疗顽固性心力衰竭是处理心力衰竭方面的新进展,文献中屡有报道。晚近对盐酸哌唑嗪的扩血管作用研究,认为该药对高血压和难治性心力衰竭患者确有显著疗效,并对一些冠心病心绞痛和急性心肌梗塞所致的充血性心力衰竭也有一定的效果。本院内科从1981年6月以来,应用盐酸哌唑嗪(prazosin hydrochloride;以下简称哌唑嗪)治疗冠心病心绞痛或心功能不全者9例及风心病联合瓣膜病变伴心功能不全者1例,取得了一定的临床效果,介绍如下:
Treatment of refractory heart failure with vasodilators is a new advance in the treatment of heart failure and is frequently reported in the literature. Recent vasopressin hydrochloride vasodilator study, that the drug for patients with hypertension and refractory heart failure did have a significant effect, and some of coronary heart disease angina and acute myocardial infarction caused by congestive heart failure also have a certain effect. Our hospital since June 1981, the application of prazosin hydrochloride (prazosin hydrochloride) for the treatment of coronary heart disease or heart failure in 9 cases and rheumatic heart disease associated with valvular heart disease in 1 case, Has made a certain clinical effect, described as follows: